Published on
February 18, 2025
- 13:35 GMT
Solaris Endovascular, Inc. Surpasses Key Enrollment Milestone in DEScover Randomized Clinical Trial
42 Patients Enrolled in Pioneering Drug-Eluting Covered Stent Graft Study NEW ORLEANS, LA, UNITED STATES, February 19, 2025 /EINPresswire.com/ -- Solaris Endovascular, Inc., a leading US-based medical device company specializing in advanced endovascular …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
